Payden & Rygel’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-292,800
Closed -$17.9M 115
2025
Q1
$17.9M Buy
292,800
+45,000
+18% +$2.74M 1.53% 25
2024
Q4
$14M Buy
+247,800
New +$14M 1.21% 41
2024
Q2
Sell
-3,800
Closed -$206K 125
2024
Q1
$206K Hold
3,800
0.01% 115
2023
Q4
$195K Hold
3,800
0.01% 123
2023
Q3
$221K Hold
3,800
0.02% 117
2023
Q2
$243K Sell
3,800
-203,940
-98% -$13M 0.02% 115
2023
Q1
$14.4M Sell
207,740
-235,320
-53% -$16.3M 0.85% 58
2022
Q4
$31.9M Sell
443,060
-4,200
-0.9% -$302K 1.7% 18
2022
Q3
$31.8M Buy
447,260
+77,800
+21% +$5.53M 1.86% 13
2022
Q2
$28.4M Hold
369,460
1.71% 16
2022
Q1
$27M Sell
369,460
-352,500
-49% -$25.7M 1.36% 29
2021
Q4
$45M Buy
721,960
+5,800
+0.8% +$362K 2.08% 5
2021
Q3
$42.4M Buy
716,160
+371,460
+108% +$22M 2.2% 6
2021
Q2
$23M Sell
344,700
-123,600
-26% -$8.26M 1.1% 50
2021
Q1
$29.6M Buy
468,300
+9,300
+2% +$587K 1.37% 33
2020
Q4
$28.5M Sell
459,000
-6,400
-1% -$397K 1.46% 33
2020
Q3
$28.1M Sell
465,400
-102,000
-18% -$6.15M 1.66% 25
2020
Q2
$33.4M Sell
567,400
-7,100
-1% -$417K 2.13% 10
2020
Q1
$32M Buy
574,500
+40,508
+8% +$2.26M 2.31% 13
2019
Q4
$34.3M Buy
533,992
+217,000
+68% +$13.9M 2.14% 15
2019
Q3
$16.1M Buy
+316,992
New +$16.1M 1.09% 44
2015
Q3
Sell
-240
Closed -$16K 127
2015
Q2
$16K Hold
240
﹤0.01% 152
2015
Q1
$15K Hold
240
﹤0.01% 168
2014
Q4
$14K Hold
240
﹤0.01% 169
2014
Q3
$12K Hold
240
﹤0.01% 174
2014
Q2
$12K Hold
240
﹤0.01% 187
2014
Q1
$12K Buy
240
+140
+140% +$7K ﹤0.01% 183
2013
Q4
$5K Hold
100
﹤0.01% 209
2013
Q3
$5K Hold
100
﹤0.01% 192
2013
Q2
$4K Buy
+100
New +$4K ﹤0.01% 205